AmCad BioMed Corporation (TPEX:4188)

AmCad BioMed Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 2, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,061	1,415	1,422	849	1,030	1,027
Market Cap Growth	-29.63%	-0.45%	67.51%	-17.57%	0.26%	-19.90%
Enterprise Value	762	1,050	1,236	617	758	726
Last Close Price	16.75	22.35	26.12	15.60	18.93	18.88
PS Ratio	24.33	26.66	21.79	13.77	12.00	16.06
PB Ratio	1.71	2.13	2.98	1.63	1.78	1.73
P/TBV Ratio	2.26	2.82	4.63	2.48	2.62	2.57
EV/Sales Ratio	17.49	19.77	18.94	10.01	8.84	11.35
EV/FCF Ratio	-14.00	-	-	-	-	-
Debt / Equity Ratio	0.01	0.02	0.03	0.02	0.03	0.01
Asset Turnover	0.08	0.09	0.12	0.11	0.14	0.09
Inventory Turnover	0.69	0.73	1.00	1.06	1.17	1.04
Quick Ratio	22.77	15.37	12.23	12.26	14.43	8.38
Current Ratio	24.52	16.63	13.35	13.15	15.33	8.85
Return on Equity (ROE)	-11.72%	-9.26%	-8.65%	-9.89%	-4.58%	-6.98%
Return on Assets (ROA)	-8.27%	-6.69%	-6.33%	-6.87%	-3.61%	-5.06%
Return on Capital (ROIC)	-8.51%	-6.93%	-6.60%	-7.15%	-3.85%	-5.64%
Earnings Yield	-5.32%	-3.57%	-3.19%	-6.30%	-2.48%	-3.45%
FCF Yield	-5.13%	-3.85%	-2.95%	-4.10%	-4.01%	-4.90%
Buyback Yield / Dilution	-17.23%	-8.42%	-0.01%	-	-0.09%	-0.36%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.